Studies suggest a tumour suppressive role for FOXO3, as pharmacological inhibition of PI3K-AKT-mTOR signalling resulted in dephosphorylation and activation of FOXO3 leading to a reduction in MCL cell survival and proliferation (110). The gene discussed is FOXO3; the disease is mantle cell lymphoma.